25TFM-NBOMe
Chemical compound
From Wikipedia, the free encyclopedia
25TFM-NBOMe (also known as NBOMe-2C-TFM, 2C-TFM-NBOMe, and Cimbi-138) is a derivative of the phenethylamine hallucinogen 2C-TFM, discovered by Ralf Heim at the Free University of Berlin by 2000.[1][2] It can be taken to produce psychedelic effects similar to 25I-NBOMe and 25D-NBOMe.[citation needed]
| Clinical data | |
|---|---|
| Other names | NBOMe-2C-TFM; 2C-TFM-NBOMe; Cimbi-138 |
| Drug class | Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H22F3NO3 |
| Molar mass | 369.384 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Interactions
Pharmacology
Pharmacodynamics
| Target | Affinity (Ki, nM) |
|---|---|
| 5-HT1A | ND |
| 5-HT1B | ND |
| 5-HT1D | 1,817 |
| 5-HT1E | ND |
| 5-HT1F | ND |
| 5-HT2A | 0.35–0.49 (Ki) 0.96–2.0 (EC50) 80–92% (Emax) |
| 5-HT2B | 1.1 (Ki) ND (EC50) ND (Emax) |
| 5-HT2C | 2.7 (Ki) (rat) 11.5 (EC50) 110% (Emax) |
| 5-HT3 | ND |
| 5-HT4 | ND |
| 5-HT5A | 8,128 |
| 5-HT6 | 23.4 |
| 5-HT7 | 5,974 |
| α1A–α1D | ND |
| α2A–α2C | ND |
| β1–β3 | ND |
| D1–D5 | ND |
| H1–H4 | ND |
| M1–M5 | ND |
| I1 | ND |
| σ1, σ2 | ND |
| ORs | ND |
| TAAR1 | ND |
| SERT | ND (Ki) ND (IC50) ND (EC50) |
| NET | ND (Ki) ND (IC50) ND (EC50) |
| DAT | ND (Ki) ND (IC50) ND (EC50) |
| Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified. Refs: [3][4][5][6] | |
25TFM-NBOMe acts as a potent partial agonist for the serotonin 5-HT2A receptor, though its relative potency is disputed, with some studies finding it to be of lower potency than 25I-NBOMe,[7][8] while others show it to be of similar or higher potency,[9] possibly because of differences in the assay used.[10]
Chemistry
History
25TFM-NBOMe was first described in the scientific literature by Ralf Heim and colleagues at the Free University of Berlin by 2000.[1][2]
Society and culture
Legal status
Canada
25TFM-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.[11]
United Kingdom
This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[12]